Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/4201
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStich, August-
dc.contributor.authorPonte-Sucre, Alicia-
dc.contributor.authorHolzgrabe, Ulrike-
dc.date.accessioned2013-09-20T02:22:10Z-
dc.date.available2013-09-20T02:22:10Z-
dc.date.issued2013-09-19-
dc.identifier.issn1474-4457-
dc.identifier.urihttp://hdl.handle.net/10872/4201-
dc.description.sponsorshipDFG-Germanyes_VE
dc.language.isoenes_VE
dc.relation.ispartofseriesLancet Infectious Diseases;13: 733-734, 2013.-
dc.subjectTrypanosoma bruceies_VE
dc.subjectnew drugses_VE
dc.titleDo we need new drugs against Human African trypanosomiasis?es_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Stich et al. Lancet2013.pdf286.17 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.